147 related articles for article (PubMed ID: 7117731)
1. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
Hong E
Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
[No Abstract] [Full Text] [Related]
2. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological properties of indolylalkyl derivatives of quipazine].
Trubitsyna TK; Kashkovskiĭ MD
Farmakol Toksikol; 1980; 43(5):530-6. PubMed ID: 7449980
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
[No Abstract] [Full Text] [Related]
5. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
Lansdown MR; Nash HL; Preston PR; Wallis DI
Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
[No Abstract] [Full Text] [Related]
6. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Langlais PJ; Gabay S
J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
[TBL] [Abstract][Full Text] [Related]
7. Effects of serotonin agonists on lordosis, myoclonus, and cytoplasmic progestin receptors in guinea pigs.
O'Connor LH; Feder HH
Horm Behav; 1983 Jun; 17(2):183-96. PubMed ID: 6885006
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
[No Abstract] [Full Text] [Related]
9. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat].
Fischer W; Müller M
Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385
[No Abstract] [Full Text] [Related]
10. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
[No Abstract] [Full Text] [Related]
11. Action of serotoninmimetics in the behavioral despair test in rats.
Górka Z; Wojtasik E; Kwiatek H; Maj J
Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
[No Abstract] [Full Text] [Related]
12. [Study of the pharmacology of quipazine maleate. 3. Possible analogies between serotonin and quipazine maleate].
Pardo EG; Hong E; Sancillo LF; Vargas R
Gac Med Mex; 1969 Aug; 99(8):758-64. PubMed ID: 5822129
[No Abstract] [Full Text] [Related]
13. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
[No Abstract] [Full Text] [Related]
14. Similarities between the pharmacological actions of quipazine and serotonin.
Hong E; Sancilio LF; Vargas R; Pardo EG
Eur J Pharmacol; 1969; 6(3):274-80. PubMed ID: 5816391
[No Abstract] [Full Text] [Related]
15. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
[No Abstract] [Full Text] [Related]
16. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
Jacoby JH; Poulakos JJ
J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
[No Abstract] [Full Text] [Related]
17. Synthesis and 5HT-receptors affinity of some 4-phenylquinoline derivatives.
Anzini M; Vomero S; Garofalo A; Cappelli A; Cagnotto A
Farmaco; 1989 Jun; 44(6):555-63. PubMed ID: 2529861
[TBL] [Abstract][Full Text] [Related]
18. Quipazine-induced stimulus control in the rat.
Winter JC
Psychopharmacology (Berl); 1979 Feb; 60(3):265-9. PubMed ID: 108704
[No Abstract] [Full Text] [Related]
19. Anticholinergic, antihistaminic and cardiovascular effects of two new congeners of quipazine and trazodone.
Alhaider AA
Arzneimittelforschung; 1993 Nov; 43(11):1141-4. PubMed ID: 7904818
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
Rowland N; Carlton J; Bartness T; Smith G
Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
